The results of column chromatography purification indicated that all the three tested clones of in vitro A. annua plantlets contained between 2.90 and 3.75 mg/g of artemisinin with Highland clone (3.75 mg/g) and TC2 clone (3.55 mg/g) produced higher artemisinin as compared to TC1 clone.
As expected, macrophages from 10 mg zymosan produced high levels of TNFα, IL-12p40, as well as MIP-1α and MIP-1β, for instance, along with lower levels of IL-10.
Oral dosages of 20 mg/kg/day of TMP produced higher concentrations which resulted in a high incidence of toxicities [7].
Higher doses (80 mg/kg/day) produced higher tumor VEGF than control baseline.
Oral dosages of 20 mg/kg/day of TMP produced higher concentrations which resulted in a high incidence of toxicities [ 7].
IVR 0.5 mg produced a significantly higher improvement in visual acuity at six months, with pooled weighted mean differences (WMDs) of 12.30 early treatment diabetic retinopathy study (ETDRS) letters (95% CI 10.03, 14.58) (P < 0.001),and led to a higher proportion of patients gaining ≥15 letters (RR, 2.36; 95%CI: 1.86, 2.99; P < 0.001) at the follow-up endpoint, compared with non-anti-VEGF.
Rates of stroke for patients aged ≥75 years compared with younger patients were not reported for dabigatran; however, dabigatran showed a significant interaction of age by treatment, with both dabigatran 110 mg and dabigatran 150 mg producing a higher risk of major bleeding in patients aged ≥75 years compared with those aged <75 years [ 100].
(16) Samples with 0.3−1 mg of C consistently produced high-quality graphite with high throughput using our optimized method.
In patients with cystic fibrosis, the equivalent of 160 mg colistimethate sodium (CMS) produced high and therapeutic endobronchial concentrations [ 2].
The Al Mg/Mg foils were deposited from pure Al and Mg targets in a co-planar configuration, conditions having been initially found that produced high hardness/high strength amorphous Al Mg alloy foils.
